Pioglitazone and nephrolithiasis

Sheng-Wen Niu¹, Jiun Shiuan He², Hugo You-Hsien Lin³

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
² Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
³ Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; Department of Physiology and Biophysics, University of California at Irvine, Irvine, California, USA. Electronic address: yukenlin@gmail.com.

PMID: 31331471
DOI: 10.1016/j.kint.2019.04.015

Free article

Comment

Pioglitazone and nephrolithiasis

Sheng-Wen Niu et al. Kidney Int. 2019 Aug.

Free article

. 2019 Aug;96(2):518-519.

doi: 10.1016/j.kint.2019.04.015.

Authors

Sheng-Wen Niu¹, Jiun Shiuan He², Hugo You-Hsien Lin³

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
² Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
³ Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; Department of Physiology and Biophysics, University of California at Irvine, Irvine, California, USA. Electronic address: yukenlin@gmail.com.

PMID: 31331471
DOI: 10.1016/j.kint.2019.04.015

No abstract available

PubMed Disclaimer

Comment in

The authors reply.
Sakhaee K, Maalouf N. Sakhaee K, et al. Kidney Int. 2019 Aug;96(2):519. doi: 10.1016/j.kint.2019.04.016. Kidney Int. 2019. PMID: 31331472 No abstract available.

Comment on

Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
Maalouf NM, Poindexter JR, Adams-Huet B, Moe OW, Sakhaee K. Maalouf NM, et al. Kidney Int. 2019 May;95(5):1262-1268. doi: 10.1016/j.kint.2018.11.024. Epub 2019 Feb 19. Kidney Int. 2019. PMID: 30795852 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Pioglitazone and nephrolithiasis

Affiliations

Pioglitazone and nephrolithiasis

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical